Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy, Biologic therapy.

Kliniken Essen-Mitte, Essen, Germany.

Survival: monthsCountry:Germany
Toxiciy Grade:4City/State/Province:Essen
Treatments:Chemotherapy, Biologic therapyHospital:Kliniken Essen-Mitte
Drugs:Journal:Link
Date:Dec 2013

Description:

Patients:
This phase 2 study involved 15 recurrent ovarian cancer patients who had received prior chemotherapy. The median patient age was 60 years.

Treatment:
Patients received chemotherapy with pegylated liposomal doxorubicin and biologic therapy with vandetanib, a tyrosine kinase inhibitor.

Toxicities:
The most severe toxicities were of grade 4 and included grade 3-4 hand-foot syndrome and mucosal inflammation.

Results:
The median overall survival was 11.1 months.

Support:
This study was supported by AstraZeneca.

Correspondence: Dr. Philipp Harter; email: [email protected]



Back